GlassScriptPhysician profile
Kevin E Varner
NPI 1891731303
$1,053,444.17
in general payments reported to CMS, 2019-2025
16 companies · $79K in 2025
The $79K reported for 2025 was more than what 94% of Foot and Ankle Surgery providers received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $79K · 2020: $85K · 2021: $103K · 2022: $510K · 2023: $131K · 2024: $66K · 2025: $79K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $204K · Acquisitions: $54K · Consulting Fee: $12K · Travel and Lodging: $5,449 · Food and Beverage: $1,684.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $203,963.95 |
| Acquisitions | $53,555.64 |
| Consulting Fee | $12,000.00 |
| Travel and Lodging | $5,449.03 |
| Food and Beverage | $1,684.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $665,433.36 | 2022-2025 | Fracture and Correction Colag 2, 5ms, Colink Afx |
| In2bones USA, LLC | $276,923.63 | 2019-2022 | |
| Stryker Corporation | $58,234.01 | 2020-2022 | |
| Wright Medical Technology, INC. | $43,773.14 | 2019-2020 | |
| Theramicro, INC. | $6,678.16 | 2025 | Tekbrace Solo |
| Vilex LLC | $1,419.14 | 2025 | Hintermann |
| Ossur Americas, INC. | $256.74 | 2024-2025 | |
| Depuy Synthes Sales INC. | $192.60 | 2021-2024 | Na |
| Bioventus LLC | $131.82 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Acumed LLC | $123.16 | 2022-2024 | Acumed |
| Trilliant Surgical LLC. | $96.54 | 2022 | |
| Radius Health, INC. | $70.63 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $52.29 | 2023 | Iovera, Zilretta, Exparel |
| Vertex Pharmaceuticals Incorporated | $27.08 | 2025 | |
| Wound Management Technologies, INC | $20.50 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dynasplint Systems INC. | $11.37 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$55,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Varner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.